Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024

Zugriffe
Effectiveness ...17

Gesamtzugriffe pro Monat

September 2025Oktober 2025November 2025Dezember 2025Januar 2026Februar 2026März 2026
Effectiveness ...00000017

Dateiabrufe

Zugriffe
Influenza Resp Viruses - 2024 - Merdrignac - Effectiveness of XBB 1 5 Vaccines Against Symptomatic SARS‐CoV‐2 Infection in.pdf7